- Home
- YALA vs COLL Comparison
YALA vs COLL Comparison
Compare YALA & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YALA
- COLL
- Stock Information
- Founded
- YALA 2016
- COLL 2002
- Country
- YALA United Arab Emirates
- COLL United States
- Employees
- YALA N/A
- COLL N/A
- Industry
- YALA Computer Software: Programming Data Processing
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- YALA Technology
- COLL Health Care
- Exchange
- YALA Nasdaq
- COLL Nasdaq
- Market Cap
- YALA 1.1B
- COLL 958.8M
- IPO Year
- YALA 2020
- COLL 2015
- Fundamental
- Price
- YALA $6.77
- COLL $30.51
- Analyst Decision
- YALA
- COLL Strong Buy
- Analyst Count
- YALA 0
- COLL 4
- Target Price
- YALA N/A
- COLL $43.75
- AVG Volume (30 Days)
- YALA 670.1K
- COLL 282.0K
- Earning Date
- YALA 08-11-2025
- COLL 08-07-2025
- Dividend Yield
- YALA N/A
- COLL N/A
- EPS Growth
- YALA 8.53
- COLL N/A
- EPS
- YALA 0.77
- COLL 1.25
- Revenue
- YALA $344,824,034.00
- COLL $664,283,000.00
- Revenue This Year
- YALA $8.87
- COLL $20.04
- Revenue Next Year
- YALA $5.56
- COLL $3.98
- P/E Ratio
- YALA $8.73
- COLL $24.37
- Revenue Growth
- YALA 6.40
- COLL 17.17
- 52 Week Low
- YALA $3.71
- COLL $23.23
- 52 Week High
- YALA $8.29
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- YALA 49.99
- COLL 60.67
- Support Level
- YALA $6.17
- COLL $29.28
- Resistance Level
- YALA $6.89
- COLL $30.83
- Average True Range (ATR)
- YALA 0.26
- COLL 0.73
- MACD
- YALA 0.03
- COLL 0.01
- Stochastic Oscillator
- YALA 77.63
- COLL 81.71
About YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The Group has one operating segment, which is the social networking and entertainment platform.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.